A Dual-Type L2 11-88 Peptide from HPV Types 1618 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
Joint Authors
Azadmanesh, Kayhan
Motavalli Khiavi, Farhad
Arashkia, Arash
Golkar, Majid
Nasimi, Maryam
Roohvand, Farzin
Source
Journal of Immunology Research
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-15, 15 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-05-03
Country of Publication
Egypt
No. of Pages
15
Main Subjects
Abstract EN
E.
coli-derived concatenated, multitype L2-conserved epitopes of human papillomavirus (HPV) L2 protein might represent a less expensive and pan-type vaccine alternative (compared to type-specific HPV L1 virus-like particles), if stable protein expression and strong immunogenicity features could be met.
Herein, three dual-type- (DT-) HPV L2 fusion peptides comprising the three head-to-tail tandem repeats (multimers) of either HPV 16 epitope “17-36” or “69-81” or one copy (monomer) of 11-88 fused to the same residues of HPV 18 were constructed and expressed in E.
coli.
SDS-PAGE and Western blot analyses indicated the proper expression and stability of the E.
coli-derived DT peptides.
Mice immunized by formulation of the purified DT peptides and Freund’s adjuvant (CFA/IFA) raised neutralizing antibodies (NAbs; the highest for DT: 11-88 peptide) which showed proper cross-reactivity to HPV types: 18, 16, 31, and 45 and efficiently neutralized HPV 18/16 pseudoviruses in vitro.
Immunization studies in mice by formulation of the DT: 11-88 × 1 peptide with various adjuvants (alum, MF59, and Montanides ISA 720 and 50) indicated that Montanide adjuvants elicited the highest cross-reactive titers of NAbs and similar levels of IgG1 and IgG2a (switching towards balanced Th1/Th2 responses).
The results implied development of low-cost E.
coli-derived DT: 11-88 peptide formulated in human compatible ISA 720 adjuvant as a HPV vaccine.
American Psychological Association (APA)
Motavalli Khiavi, Farhad& Arashkia, Arash& Golkar, Majid& Nasimi, Maryam& Roohvand, Farzin& Azadmanesh, Kayhan. 2018. A Dual-Type L2 11-88 Peptide from HPV Types 1618 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice. Journal of Immunology Research،Vol. 2018, no. 2018, pp.1-15.
https://search.emarefa.net/detail/BIM-1193305
Modern Language Association (MLA)
Motavalli Khiavi, Farhad…[et al.]. A Dual-Type L2 11-88 Peptide from HPV Types 1618 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice. Journal of Immunology Research No. 2018 (2018), pp.1-15.
https://search.emarefa.net/detail/BIM-1193305
American Medical Association (AMA)
Motavalli Khiavi, Farhad& Arashkia, Arash& Golkar, Majid& Nasimi, Maryam& Roohvand, Farzin& Azadmanesh, Kayhan. A Dual-Type L2 11-88 Peptide from HPV Types 1618 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice. Journal of Immunology Research. 2018. Vol. 2018, no. 2018, pp.1-15.
https://search.emarefa.net/detail/BIM-1193305
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1193305